We describe an electroimmunodiffusion technique for measuring a1-fetoprotein in blood spotted on chromatography paper. The system is being used as a complementary test in a neonatal mass-screening program for detection of inborn metabolic diseases in the Province of Quebec. In a series of 102 cases of neonatal hypertyrosinemia, the test has proven to be highly discriminative for hereditary tyrosinemia. It has permitted earlydetectionof eight cases of this disease, including two that would have been missed by the previously used screening procedure, tyrosine measurement only. The test not only virtually eliminates the risk of misdiagnosis or missed diagnosis, but also permits earlier diagnosis of hereditary tyrosinemia and considerably reduces the follow-up work required for newborns with transitory tyrosinemia. The AFP test is simple, fast, practical, and inexpensive. Combined with tyrosine determination, it constitutes an optimal device for mass screening of hereditary tyrosinemia.
Electrophoresis chamber:
A Spinco paper electrophoresis chamber was used (Model R, Series D) combined to a Gelman power supply (Model 38201).
Method

Preparation of Samples
Test samples were prepared by eluting (2 h at room temperature) dried blood from 7.94-mm paper disks (Schleicher and Schuell No. 903c) into 0.25 ml of 0.15 mol/liter NaC1.
Preparation of Gel Plates
Attempts to run these whole blood specimens in conventional electroimmunodiffusion gel plates (9) resulted in substantial nonspecific precipitation of protein, which precluded analysis of immune precipitates. To eliminate this problem, we devised doublecompartment plates such that the nonspecific precipitation is allowed to take place in an antibody-free section of the gel while AFP-anti-AFP immune precipitation takes place in a second, antibody-containing, gel section ( Figure 1 ).
Fig. 1. Measurement of AFP in paper-spotted blood specimens on double compartment electroimmunodiffusion plates
Left to right: 50, 25. 10, and 5 mg/liter AFP standards, followed by duplicates of &ied-blood samples. Note the straight-cut line (am,*) that separates sections of the gel that do and do not contain antibody. The optimal concentration of anti-AFP serum in the antibody-containing gel section has been experimentally determined to be the one that will produce a 60 mm immune rocket when a 100 mg/liter AFP standard is run in the regular electroimmunodiffuslon plate. Under routine conditions of assay, the sensitivity limit of the system is 2 mg/liter (that is, for &ied-blood samples, 30 mg/liter of serum after multiplication by the correction factor'S described in the text) As shown in Figure 1 , the maximal discrepancy between serum and blood spot results is 25%. Although the accuracy index is admittedly poor, it in no way affects the practical usefulness of the system (see next section).
Results
Method
Screening
We included in this study 94 We emphasize here that, of the eight patients with hereditary tyrosinemia, two had normal blood tyrosine concentrations (35 and 56 mg/liter, see Figure 2 ) at the second test and so would have been missed by the usual screening procedure. Therefore, in contrast with tyro- (11, 12) . Because all tyrosinemics we have studied to this time have had 3The reported fmdings of high serum AFP concentrations in Indian childhood cirrhosis (13) and in cystic fibrosis (14) have not been confirmed (15) (16) (17) (18) (19) 
